Dr. Kimberly L. Blackwell on a Promising HER2 Breast Cancer Treatment
Kimberly L. Blackwell, MD, professor of Medicine, assistant professor of Radiation Oncology, Duke Cancer Institute, discusses upcoming trials for the HER2-antibody margetuximab.